Collecting cerebrospinal fluid correctly can affect Alzheimer’s disease diagnosis … Abnormal proteins tied to ALS, dementia … People on respiratory support in rural clinics have higher death rates...
Clinical briefs for Wednesday, Jan. 31
By
Kristen Fischer
Jan 31, 2024
Gut health has a say in respiratory virus severity, study finds … Virtual reality’s push into palliative care … Smoking ups ALS odds by 12%
Also in the News for Friday, Sept. 22
By
Kimberly Marselas
Sep 22, 2023
CMS updates quality measures to align with coming MDS changes … CCRC ratings unlikely to be affected by SNF staffing mandates: Fitch … US employers facing largest increase in healthcare costs in a...
ALS drug ‘significantly’ slows disease progression in late-stage trial
By
Alicia Lasek
Dec 17, 2019
Participants taking AMX0035 had slower ALS disease progression than those given a placebo, the drug’s developer reports.
Also in the News for Tuesday, Feb. 6
By
Kimberly Marselas
Feb 06, 2018
NY Times draws new attention to role immigrants play in elder care … Federal watchdog says patchwork of regulation jeopardizing assisted living residents … Facing lawsuit, VA extends home healthcare...
Chelsea Jewish Foundation honored with Gold Award in McKnight’s Technology Awards
By
McKnight's Staff
Oct 03, 2012
Boston’s Chelsea Jewish Foundation won the top prize in the High Tech/High Touch category of McKnight’s Excellence in Technology Awards — Connect Our World.
Are you ready for some (neurodegenerative disease inducing) football?
By
John O'Connor
Sep 07, 2012
Football has become our national sport. This wonderful, tough game has been turning boys into men for generations. But it may also be turning men into nursing home residents way before their time.
Lithium might have protective effect against Parkinson’s disease, study finds
Jun 27, 2011
The drug lithium has been found to greatly prevent the buildup of the toxic proteins and brain cell loss linked to Parkinson’s disease, according to a study conducted on laboratory mice.